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SUMMARY OF THESIS*
OKAY, Thelma Suely - Diagnóstico molecular da toxoplasmose congênita. Expressão de genes específicos de estágio parasitário em amostras
de líquido amniótico. São Paulo, 2005. (Tese de Livre-Docência - Faculdade de Medicina da Universidade de São Paulo).
MOLECULAR DIAGNOSIS OF CONGENITAL TOXOPLASMOSIS. EXPRESSION OF PARASITE STAGE-
SPECIFIC GENES IN AMNIOTIC FLUID SAMPLES
One hundred amniotic fluid samples of pregnant women who
seroconverted to toxoplasmosis and were treated were analyzed by
DNA-PCR-B1. There were 50 positive and 50 negative amniotic fluid
samples. Afterwards, a DNA-nested-PCR-B1 was conducted and
detected other nine cases in a total of 50 previously negative samples
(9/50 or 18%). The McNemar test found discordance between the two
amplification tests (p = 0.027; α = 5%). In the second part of the study,
we determined the efficiency of treatment by means of three RT-nested-
PCR (B1, SAG1, BAG1). The B1 gene is expressed in all parasite
forms, while SAG1 is specific of tachyzoites and BAG1 of bradyzoites.
Among 59 DNA-positive samples, six were positive by RT-nested-
PCR (four with B1, and two with SAG1). Thus, 53 of 59 (89.83%)
women did not present with parasite replication, while 6/59 (10.17%)
did, indicating therapeutic failure. The two positive SAG1 fetuses had
hydrocephalus. There were three samples that were RT-nested-PCR-
B1 positive and DNA-nested-PCR negative, therefore indicating false-
negative results of DNA amplification (3/50 or 6.9%). In conclusion,
the DNA-nested-PCR-B1 is superior to the one-round amplification,
and the anti-Toxoplasma treatment seems to be efficient to stop parasite
replication. Further studies are needed to confirm whether RT-nested-
PCR-SAG1 might act as a prognostic marker in infected fetuses.
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